Before I get into the main theme of the article, I want to make a market-cap comparison of T2 Biosystems (TTOO) and Accelerate Diagnostics (AXDX). Reason being, to investigate if TTOO is undervalued in comparison to AXDX or not.
AXDX is a Vitro diagnostics company that offers a diagnostic platform for the identification of pathogens and antibiotic susceptibility testing (ID/AST). However this is a very crowded sector, with much bigger players such as bioMérieux (BMXXY) and privately held Beckman Coulter. TTOO on the other hand has no competition, because